Parsons Agata M, Byrne Seth, Kooistra Jesse, Dewey John, Zebolsky Aaron L, Alvarado Gloria, Bouma Gerrit J, Vanden Heuvel Gregory B, Larson Erik D
Department of Biomedical Sciences, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA.
Nat Commun. 2025 Jan 2;16(1):121. doi: 10.1038/s41467-024-55684-y.
The "secondhit" pathway is responsible for biallelic inactivation of many tumor suppressors, where a pathogenic germline allele is joined by somatic mutation of the remaining functional allele. The mechanisms are unresolved, but the human PKD1 tumor suppressor is a good experimental model for identifying the molecular determinants. Inactivation of PKD1 results in autosomal dominant polycystic kidney disease, a very common disorder characterized by the accumulation of fluid-filled cysts and end-stage renal disease. Since human PKD1 follows second hit and mouse Pkd1 heterozygotes do not, we reasoned that there is likely a molecular difference that explains the elevated mutagenesis of the human gene. Here we demonstrate that guanine quadruplex DNA structures are abundant throughout human, but not mouse, PKD1 where they activate the DNA damage response. Our results suggest that guanine quadruplex DNAs provoke DNA breaks in PKD1, providing a potential mechanism for cystogenesis in autosomal dominant polycystic kidney disease specifically and for the inactivation of guanine quadruplex-rich tumor suppressors generally.
“二次打击”途径导致许多肿瘤抑制基因的双等位基因失活,即一个致病的种系等位基因通过剩余功能等位基因的体细胞突变而失活。其机制尚不清楚,但人类多囊肾病1(PKD1)肿瘤抑制基因是鉴定分子决定因素的良好实验模型。PKD1失活会导致常染色体显性多囊肾病,这是一种非常常见的疾病,其特征是充满液体的囊肿积聚和终末期肾病。由于人类PKD1遵循二次打击机制,而小鼠Pkd1杂合子则不然,我们推断可能存在分子差异来解释人类基因诱变率的升高。在此,我们证明鸟嘌呤四链体DNA结构在整个人类PKD1基因中大量存在,而在小鼠PKD1基因中则不然,它们在人类PKD1基因中激活DNA损伤反应。我们的结果表明,鸟嘌呤四链体DNA会引发PKD1基因中的DNA断裂,这为常染色体显性多囊肾病中囊肿形成以及富含鸟嘌呤四链体的肿瘤抑制基因的失活提供了潜在机制。